Publications

2023

Identification and Biological Evaluation of a Potent and Selective JAK1 Inhibitor for the Treatment of Pulmonary Fibrosis

Park E, Park S, Lee S.J, Jeong D, Jin H, Moon H, Cha B, Kim D, Ma S, Seo W, Han SH, Lee YS, Kang S

J. Med. Chem. 2023, 66, 16342;  doi.org/10.1021/acsjmedchem.3c01712

Tsaokoic Acid: A New Bicyclic Nonene from the Fruits of Amomum tsao-ko with Acetylcholinesterase Inhibitory Activity.

Kim H, Lee H, Jung HJ, Noh SG, Youn U I, Kwak H, Lee Y, Nam SJ, Kang S, Chung HY, Seo E.

Molecules 2023, 28(6), 2602; https://doi.org/10.3390/molecules28062602

Meclizine, a piperazine-derivative antihistamine, binds to dimerized translationally controlled tumor protein and attenuates allergic reactions in a mouse model.

Jang EW, Bae HD, Jeon Y, Shin DH, Kang S, Lee K

Biomedicine & Pharmacotherapy 2023, 157, 114072; doi.org/10.1016/j.biopha.2022.114072

2022

Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1.

Kang BH and Kang S.

J. Med. Chem. 2022, 65, 16155-16172; doi.org/10.1021/acsjmedchem.2c01633

Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer’s disease agents.

Manh NV,  Hoang VH, Ngo TH, Kang S, Jeong JJ, Ha H, Kim H, Kim YH, Ann J, Lee J.

Euro. J. Med. Chem. 2022, 244, 114837; doi.org/10.1016/j.ejmech.2022.114837

2-Amino-1,3,4-thiadiazole Derivative as QC/isoQC Inhibitor Increases Phagocytosis through Modification of CD47-SIRPα Checkpoint.

Park E, Song K, Kim D, Lee M, Manh NV, Kim H, Hong KB, Lee J, Song JY, Kang S.

ACS Med Chem Lett. 2022, 13, 1459-1467; doi: 10.1021/acsmedchemlett.2c00256

Triphenylphosphonium conjugation to a TRAP1 inhibitor, 2-amino-6-chloro-7,9-dihydro-8H-purin-8-one increases antiproliferative activity.

Yang S, Yoon NG, Park M, Yun J, Im JY, Kang BH, Kang S.

Bioorganic Chemistry 2022, 126, 105856; doi: 10.1016/j.bioorg.2022.105856.

Palladium-Catalyzed α‑Arylation of Cyclic β‑Dicarbonyl Compounds for the Synthesis of CaV1.3 Inhibitors

Yun J, Jeong D, Xie, Zhong, Kim J, Surmeier DJ, Silverman R, Kang S.

ACS Omega 2022, 7,14252-14263;  doi: 10.1021/acsomega.2c00889.

2021

Mitoquinone Inactivates Mitochondrial Chaperone TRAP1 by Blocking the Client Binding Site

Yoon NG, Lee H, Kim SY,  Lim D; Yang S, Hong KB, Lee JH, Kang S, Kim BG, Myung K, Lee C, Kang BH.

J Am Chem Soc 2021, 143, 19684-19696; doi: 10.1021/jacs.1c07099.

Design and Synthesis of TRAP1 Selective Inhibitors: H‑Bonding with Asn171 Residue in TRAP1 Increases Paralog Selectivity.

Yang S, Yoon NG, Kim D, Park E, Kim SY,  Lee JH, Lee C, Kang BH, Kang S.

ACS Med Chem Lett. 2021,12, 1173-1180; doi: 10.1021/acsmedchemlett.1c00213.

Discovery and Biological Evaluation of N-Methyl-pyrrolo[2,3-b]pyridine-5-carboxamide Derivatives as JAK1-Selective Inhibitors.

Park E, Lee SJ, Moon H, Park J, Jeon H, Hwang JS, Hwang H, Hong KB, Han SH, Choi S, Kang S.

J. Med. Chem. 2021, 64, 958-979;  doi: 10.1021/acs.jmedchem.0c01026.

2020 

Deciphering Fatty Acid Synthase Inhibition-Triggered Metabolic Flexibility in Prostate Cancer Cells through Untargeted Metabolomics.

Oh JE, Jung BH, Park J, Kang S, Lee H.

Cells. 2020, 9, 2447; doi: 10.3390/cells9112447.

A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium Channels.

Cooper G, Kang S, Perez-Rosello T, Guzman JN, Galtieri D, Xie Z, Kondapalli J, Mordell J, Silverman RB, Surmeier DJ.

ACS Chem Biol. 2020, 5, 2539-2550; doi: 10.1021/acschembio.0c00577.

Development of pyrazolo[3,4-d]pyrimidine-6-amine-based TRAP1 inhibitors that demonstrate in vivo anticancer activity in mouse xenograft models.

Kim D, Kim SY, Kim D, Yoon NG, Yun J, Hong KB, Lee C, Lee JH, Kang BH, Kang S.

Bioorg Chem. 2020, 101, 103901; doi: 10.1016/j.bioorg.2020.103901.

Practical direct synthesis of N-aryl-substituted azacycles from N-alkyl protected arylamines using TiCl4 and DBU.

Tran VH, La MT, Kang S, Kim HK.

Org Biomol Chem. 2020, 18, 5008-5016; doi: 10.1039/d0ob00880j.

Physiological involvement of presynaptic L-type voltage-dependent calcium channels in GABA release of cerebellar molecular layer interneurons.

Rey S, Maton G, Satake S, Llano I, Kang S, Surmeier DJ, Silverman RB, Collin T.

J Neurochem. 2020, 155, 390-402; doi: 10.1111/jnc.15100.

Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1.

Jung S, Yoon NG, Yang S, Kim D, Lee WS, Hong KB, Lee C, Kang BH, Lee JH, Kang S.

Bioorg Med Chem Lett. 2020, 30, 126809; doi: 10.1016/j.bmcl.2019.126809

2019 

Casein kinase-1γ1 and 3 stimulate tumor necrosis factor-induced necroptosis through RIPK3.

Lee SY, Kim H, Li CM, Kang J, Najafov A, Jung M, Kang S, Wang S, Yuan J, Jung YK.

Cell Death Dis. 2019, 10, 923; doi: 10.1038/s41419-019-2146-4.

Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamide.

Hieu Tran V, Park H, Park J, Kwon YD, Kang S, Ho Jung J, Chang KA, Chul Lee B, Lee SY, Kang S, Kim HK.

Bioorg Med Chem. 2019, 27, 4069-4080; doi: 10.1016/j.bmc.2019.07.036.

Metal-Free Synthesis of N-Aryl-Substituted Azacycles from Cyclic Ethers Using POCl3.

La MT, Kang S, Kim HK.

J Org Chem. 2019, 84, 6689-6696; doi: 10.1021/acs.joc.9b00377.

2018 

CF₃-Substituted Mollugin 2-(4-Morpholinyl)-ethyl ester as a Potential Anti-inflammatory Agent with Improved Aqueous Solubility and Metabolic Stability.

Hong KB, Kim D, Kim BK, Woo SY, Lee JH, Han SH, Bae GU, Kang S.

Molecules. 2018, 23, 2030; doi: 10.3390/molecules23082030.

Convenient metal-free direct oxidative amidation of aldehyde using dibromoisocyanuric acid under mild conditions.

Kang S, La MT, Kim HK.

Tetrahedron Letters 2018, 59, 3541; doi: 10.1016/j.tetlet2018.08.026.

Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery.

Macalino SJY, Basith S, Clavio NAB, Chang H, Kang S, Choi S.

Molecules. 2018, 23, 1963; doi: 10.3390/molecules23081963.

Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design.

Basith S, Cui M, Macalino SJY, Park J, Clavio NAB, Kang S, Choi S.

Front Pharmacol. 2018, 9, 128; doi: 10.3389/fphar.2018.00128.

Facile direct synthesis of unsymmetrical ureas from N-Alloc-, N-Cbz-, and N-Boc-protected amines using DABAL-Me3

Kang S, Kim HK.

Tetrahedron 2018, 74, 4036; doi: 10.1016/j.tet.2018.06.011.

2017 

Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors.

Park HK, Jeong H, Ko E, Lee G, Lee JE, Lee SK, Lee AJ, Im JY, Hu S, Kim SH, Lee JH, Lee C, Kang S, Kang BH.

J Med Chem. 2017, 60, 7569-7578; doi: 10.1021/acs.jmedchem.7b00978.

2016 

Electrostatic Control of Isoform Selective Inhibitor Binding in Nitric Oxide Synthase.

Li H, Wang HY, Kang S, Silverman RB, Poulos TL.

Biochemistry. 2016, 55, 3702-3707; doi: 10.1021/acs.biochem.6b00261.

Regulation of aldosterone secretion by CaV1.3.

Xie CB, Shaikh LH, Garg S, Tanriver G, Teo AE, Zhou J, Maniero C, Zhao W, Kang S, Silverman RB, Azizan EA, Brown MJ.

Sci Rep. 2016, 6, 24697; doi: 10.1038/srep24697.

Correction to Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.

Cinelli MA, Li H, Pensa AV, Kang S, Roman LJ, Martásek P, Poulos TL, Silverman RB.

J Med Chem. 2016, 59, 1246; doi: 10.1021/acs.jmedchem.6b00036.

2015 

Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.

Cinelli MA, Li H, Pensa AV, Kang S, Roman LJ, Martásek P, Poulos TL, Silverman RB.

J Med Chem. 2015, 58, 8694-8712; doi: 10.1021/acs.jmedchem.5b01330.

Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.

Teixeira-Castro A, Jalles A, Esteves S, Kang S, da Silva Santos L, Silva-Fernandes A, Neto MF, Brielmann RM, Bessa C, Duarte-Silva S, Miranda A, Oliveira S, Neves-Carvalho A, Bessa J, Summavielle T, Silverman RB, Oliveira P, Morimoto RI, Maciel P.

Brain. 2015, 138, 3221-3237; doi: 10.1093/brain/awv262.

2-Aminopyridines with a Truncated Side Chain To Improve Human Neuronal Nitric Oxide Synthase Inhibitory Potency and Selectivity.

Kang S, Li H, Tang W, Martásek P, Roman LJ, Poulos TL, Silverman RB.

J Med Chem. 2015, 58, 5548-5560; doi: 10.1021/acs.jmedchem.5b00573.

Nitric Oxide Synthase as a Target for Methicillin-Resistant Staphylococcus aureus.

Holden JK, Kang S, Beasley FC, Cinelli MA, Li H, Roy SG, Dejam D, Edinger AL, Nizet V, Silverman RB, Poulos TL.

Chem Biol. 2015, 22, 785-792; doi: 10.1016/j.chembiol.2015.05.013.

Inhibitor Bound Crystal Structures of Bacterial Nitric Oxide Synthase.

Holden JK, Dejam D, Lewis MC, Huang H, Kang S, Jing Q, Xue F, Silverman RB, Poulos TL.

Biochemistry. 2015, 54, 4075-4082; doi: 10.1021/acs.biochem.5b00431.

Structure-based design of bacterial nitric oxide synthase inhibitors.

Holden JK, Kang S, Hollingsworth SA, Li H, Lim N, Chen S, Huang H, Xue F, Tang W, Silverman RB, Poulos TL.

J Med Chem. 2015, 58, 994-1004; doi: 10.1021/jm501723p.

Synthesis of mevalonate- and fluorinated mevalonate prodrugs and their in vitro human plasma stability.

Kang S, Watanabe M, Jacobs JC, Yamaguchi M, Dahesh S, Nizet V, Leyh TS, Silverman RB.

Eur J Med Chem. 2015, 90, 448-461; doi: 10.1016/j.ejmech.2014.11.040.

2014 

The mobility of a conserved tyrosine residue controls isoform-dependent enzyme-inhibitor interactions in nitric oxide synthases.

Li H, Jamal J, Delker S, Plaza C, Ji H, Jing Q, Huang H, Kang S, Silverman RB, Poulos TL.

Biochemistry. 2014, 53, 5272-5279; doi: 10.1021/bi500561h.

Nitric oxide synthase inhibitors that interact with both heme propionate and tetrahydrobiopterin show high isoform selectivity.

Kang S, Tang W, Li H, Chreifi G, Martásek P, Roman LJ, Poulos TL, Silverman RB.

J Med Chem. 2014, 57, 4382-4396; doi: 10.1021/jm5004182.

Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Mukherjee P, Cinelli MA, Kang S, Silverman RB.

Chem Soc Rev. 2014, 43, 6814-6838; doi: 10.1039/c3cs60467e.

2013 

Structural and biological studies on bacterial nitric oxide synthase inhibitors.

Holden JK, Li H, Jing Q, Kang S, Richo J, Silverman RB, Poulos TL.

Proc Natl Acad Sci U S A. 2013, 110, 18127-18131; doi: 10.1073/pnas.1314080110.

Microwave-assisted protection of primary amines as 2,5-dimethylpyrroles and their orthogonal deprotection.

Walia A, Kang S, Silverman RB.

J Org Chem. 2013, 78, 10931-10937; doi: 10.1021/jo401778e.

Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.

St John SE, Jensen KC, Kang S, Chen Y, Calamini B, Mesecar AD, Lipton MA.

Bioorg Med Chem. 2013, 21, 6022-6037; doi: 10.1016/j.bmc.2013.07.037.

Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics.

Kang S, Cooper G, Dunne SF, Luan CH, James Surmeier D, Silverman RB.

Bioorg Med Chem. 2013, 21, 4365-4373; doi: 10.1016/j.bmc.2013.04.054.

Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as CaV1.3 calcium channel-selective antagonists for Parkinson's disease.

Kang S, Cooper G, Dunne SF, Luan CH, Surmeier DJ, Silverman RB.

J Med Chem. 2013, 56, 4786-4797; doi: 10.1021/jm4005048.

2012 - 1997

CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease.

Kang S, Cooper G, Dunne SF, Dusel B, Luan CH, Surmeier DJ, Silverman RB.

Nat Commun. 2012, 3, 1146; doi: 10.1038/ncomms2149.

Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels CaV1.3 and CaV1.2.

Chang CC, Cao S, Kang S, Kai L, Tian X, Pandey P, Dunne SF, Luan CH, Surmeier DJ, Silverman RB.

Bioorg Med Chem. 2010, 18, 3147-3158; doi: 10.1016/j.bmc.2010.03.038.

Synthesis of tyrosinase inhibitory (4-oxo-4H-pyran-2-yl)acrylic acid ester derivatives.

Kang S, Kim HJ, Jin C, Lee YS.

Bioorg Med Chem Lett. 2009, 19, 188-191; doi: 10.1016/j.bmcl.2008.10.119. 

Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kB.

Kang S, Cuendet M, Endringer DC, Croy VL, Pezzuto JM, Lipton MA.

Bioorg Med Chem. 2009, 17, 1044-1054; doi: 10.1016/j.bmc.2008.04.031.

Synthesis of cyclopentene-fused pyrroloisoquinolinone derivative via N-acyliminium ion cyclization

Hwang DJ, Kang S, Lee JY, Choi JH, Park H, Lee YS.

Syn. Commun. 2002, 32, 2499-2505

Asymmetric synthesis of functionalized benzo[a]quinolizine derivatives via a diastereoselective N-acyliminium ion cyclization.

Lee YS, Kang S, Choi JH, Park H.

Tetrahedron 1997, 53, 3045-3056